Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67,604,359
-
Total 13F shares
-
54,610,595
-
Share change
-
-689,240
-
Total reported value
-
$6,195,898,490
-
Put/Call ratio
-
57%
-
Price per share
-
$113.50
-
Number of holders
-
316
-
Value change
-
-$68,358,586
-
Number of buys
-
160
-
Number of sells
-
145
Institutional Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q3 2020
As of 30 Sep 2020,
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) was held by
316 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,610,595 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., Invesco Ltd., Capital World Investors, GILDER GAGNON HOWE & CO LLC, FRED ALGER MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, and FEDERATED HERMES, INC..
This page lists
316
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.